Andrew Rokito, MD
Orthopaedic Surgery · New York, NYNPI 1700880226
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (49.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Gotham Surgical Solutions & Devices, Inc. at 49.3% of the total. Reporting peaked in 2021 at $2,400 and has fallen 89.8% since, to $244 in 2024. That places this record below the midpoint for orthopaedic surgery clinicians in NY, where the typical reported total is $4,024.
Across 26 payments — averaging $187.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gotham Surgical Solutions & Devices, Inc.$2K
- Arthrex$2K
- Smith+Nephew$168
- Miach Orthopaedics, Inc.$161
- Brainlab, Inc.$55
- Johnson & Johnson$38
- plus $48 from 2 others
Across 14 payments — averaging $3756.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$35K
- Pacira Therapeutics, Inc.$17K
What the payments were for
- Travel & lodging$1,39129%
- Food & beverage$1,07922%
- Education$2,40049%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gotham Surgical Solutions & Devices, Inc. | 2 | $2,400 |
| Arthrex | 15 | $2,000 |
| Smith+Nephew | 3 | $168 |
| Miach Orthopaedics, Inc. | 1 | $161 |
| Brainlab, Inc. | 2 | $55 |
| Johnson & Johnson | 1 | $38 |
| Lilly USA, LLC | 1 | $28 |
| Exactech, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,869 in reported general payments places this provider in the 50th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 32 | $298 |
| Meloxicam | 81 | $205 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New York
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$13.2M
- William RicciNew York$11.6M
- Steven HaasNew York$11.3M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.